KR20220154923A - A process for the preparation of garlic bamboo salt and the garlic bamboo salt prepared therefrom - Google Patents
A process for the preparation of garlic bamboo salt and the garlic bamboo salt prepared therefrom Download PDFInfo
- Publication number
- KR20220154923A KR20220154923A KR1020210062474A KR20210062474A KR20220154923A KR 20220154923 A KR20220154923 A KR 20220154923A KR 1020210062474 A KR1020210062474 A KR 1020210062474A KR 20210062474 A KR20210062474 A KR 20210062474A KR 20220154923 A KR20220154923 A KR 20220154923A
- Authority
- KR
- South Korea
- Prior art keywords
- bamboo salt
- garlic
- salt
- bamboo
- prepared
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 229
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims abstract description 191
- 235000017491 Bambusa tulda Nutrition 0.000 title claims abstract description 191
- 241001330002 Bambuseae Species 0.000 title claims abstract description 191
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims abstract description 191
- 239000011425 bamboo Substances 0.000 title claims abstract description 191
- 240000002234 Allium sativum Species 0.000 title claims abstract description 140
- 235000004611 garlic Nutrition 0.000 title claims abstract description 140
- 238000000034 method Methods 0.000 title claims description 27
- 230000008569 process Effects 0.000 title claims description 12
- 238000002360 preparation method Methods 0.000 title description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- 229940029982 garlic powder Drugs 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000013078 crystal Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000002023 wood Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 244000244931 Allium canadense Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 235000013305 food Nutrition 0.000 abstract description 16
- 238000002156 mixing Methods 0.000 abstract description 10
- 150000002989 phenols Chemical class 0.000 abstract description 8
- 239000000796 flavoring agent Substances 0.000 abstract description 7
- 235000019634 flavors Nutrition 0.000 abstract description 7
- 235000011194 food seasoning agent Nutrition 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 4
- 208000008589 Obesity Diseases 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 235000020824 obesity Nutrition 0.000 abstract description 3
- 230000036642 wellbeing Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 81
- 238000012360 testing method Methods 0.000 description 25
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 13
- 230000001953 sensory effect Effects 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 11
- 238000010171 animal model Methods 0.000 description 10
- 238000011156 evaluation Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 230000006872 improvement Effects 0.000 description 9
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 8
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 8
- 206010019133 Hangover Diseases 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 8
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 7
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 230000001079 digestive effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000018823 dietary intake Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 238000013077 scoring method Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000234282 Allium Species 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 235000019784 crude fat Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 229940124600 folk medicine Drugs 0.000 description 2
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000007103 stamina Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002898 organic sulfur compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000004763 spore germination Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/105—Natural spices, flavouring agents or condiments; Extracts thereof obtained from liliaceae, e.g. onions, garlic
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
- C01D3/00—Halides of sodium, potassium or alkali metals in general
- C01D3/04—Chlorides
- C01D3/06—Preparation by working up brines; seawater or spent lyes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/212—Garlic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Abstract
Description
본 발명은 마늘죽염의 제조방법 및 이에 따라 제조된 마늘죽염에 관한 것으로서, 보다 구체적으로는 죽염에 마늘을 특정비율로 혼합시킴으로써 효능은 극대화시키고 풍미 및 맛을 향상시킴으로써 천연 조미료 및 기능성 천연식품으로 사용할 수 있는 마늘죽염의 제조방법 및 이에 따라 제조된 마늘죽염에 관한 것이다.The present invention relates to a method for manufacturing garlic bamboo salt and garlic bamboo salt prepared thereby, and more specifically, by mixing garlic with bamboo salt in a specific ratio, it can be used as a natural seasoning and functional natural food by maximizing efficacy and improving flavor and taste. It relates to a method for producing garlic bamboo salt that can be prepared and garlic bamboo salt prepared according to the method.
일반적으로 소금(NaCl)은 인간 생활에서 없어서는 안 될 중요한 요소의 하나로, 예로부터 식품 조미료뿐만 아니라 미용재료 또는 공업용 원료로서 널리 사용되어 왔다. In general, salt (NaCl) is one of the indispensable and important elements in human life, and has been widely used as a food seasoning as well as a cosmetic material or an industrial raw material.
소금은 인체 내에서 체액의 삼투압을 조절하고, 소화액을 구성하는 중요한 성분으로 생명유지에 필수적인 성분이고, 식품학적으로는 맛을 내는 가장 기본적인 조미소재이다. 소금의 종류는 크게 천일염과 정제염으로 나눌 수 있으며, 정제염은 다시 제재염과 가공염으로 분류된다. 제재염은 원료 소금을 용해, 탈수, 건조 등의 과정을 거쳐 다시 재결정화시켜 제조한 소금을 말하며, 가공염은 배소 등 가공 공정을 거친 식염을 말하는 것으로, 800℃ 이상의 고온에서 구워 식염 중의 유해성분을 제거한 죽염이 여기에 속한다. Salt is an important ingredient that regulates the osmotic pressure of body fluids in the human body and constitutes digestive juices, and is an essential ingredient for maintaining life. The types of salt can be largely divided into sun salt and refined salt, and refined salt is further classified into refined salt and processed salt. Raw salt refers to salt manufactured by re-crystallizing raw salt through processes such as dissolution, dehydration, and drying. Processed salt refers to salt that has undergone processing processes such as roasting. Removed bamboo salt belongs to this category.
최근 소득 향상에 따른 식생활의 개선으로 인해 천연 자연식품에 대한 관심이 높아지면서 민간요법으로 내려오는 우리나라 전통의 건강식품 소재에 대하여 많은 관심이 모아지고 있다. 그 중 대표적 기능성 소재의 하나인 죽염(竹鹽, Bamboo salt)은 옛날부터 우리 조상들이 대나무나 도자기 등에 소금을 넣고 고온에서 구워 소화제나 양치용 소금 등으로 사용하여 왔던 일종의 민속 의약품으로, 약리효능이 있는 죽염은 대나무에 채워 굽고 분쇄하는 횟수 및 굽는 온도에 따라 일반적으로 3회, 9회 죽염, 단염 및 자죽염 등으로 나눌 수 있다.Recently, as interest in natural foods has increased due to the improvement of dietary life due to increased income, much attention has been paid to traditional health food ingredients in Korea, which have been passed down as folk remedies. Among them, bamboo salt, one of the representative functional materials, is a kind of folk medicine that our ancestors have used as a digestive or toothpaste salt by putting salt in bamboo or pottery and roasting it at a high temperature since ancient times. Bamboo salt can be generally divided into 3 times, 9 times bamboo salt, short salt and jajuk salt according to the number of times of filling and grinding bamboo and baking temperature.
죽염의 조성은 천일염과 비슷하나 금속 원소 중 K, Ca, Fe, Zn, Mn의 함량이 천일염에 비해 높고, 중금속원소는 검출되지 않으며 pH는 10.0 부근의 알칼리성을 띠고 있는 물질이다. 최근 보고된 죽염의 효능으로는, (1) 죽염의 위염증 예방 및 개선효과, (2) 구강내 연쇄상구균의 감소 및 치은염 증상 완화효과 등이 있으며, 죽염의 약리작용 및 생리활성에 대하여 다양한 각도에서 연구가 진행 중이다. 죽염은 예로부터 위염, 위산과다, 위궤양, 구강질환, 축농증, 중이염, 초기 염증성 안질환 등의 민속약으로 사용되어 왔으며, 현재까지 전통양조식품, 건강보조식품, 치약 및 기타 제품의 부원료로 이용되고 있다.The composition of bamboo salt is similar to sun salt, but the content of K, Ca, Fe, Zn, and Mn among the metal elements is higher than that of sun salt, heavy metal elements are not detected, and the pH is alkaline around 10.0. The recently reported efficacy of bamboo salt includes (1) prevention and improvement of gastritis, (2) reduction of oral streptococci and relief of gingivitis symptoms, etc. research is ongoing in Bamboo salt has been used since ancient times as a folk medicine for gastritis, hyperacidity, gastric ulcer, oral disease, sinusitis, otitis media, and early inflammatory eye disease. have.
죽염은 다양한 미네랄이 함유되어 있어 생체활성화에 꼭 필요한 소금의 약성을 배가시키고 소금 속에 들어있는 불순물을 제거한 가공 소금으로서 소금이 쓰이는 모든 식품뿐만 아니라 치약, 비누 등 일상생활 전반에 걸쳐 굉장히 광범위하게 사용되고 있다.Bamboo salt contains various minerals, which doubles the potency of salt, which is essential for bio-activation, and is a processed salt that removes impurities from salt. .
소금의 단점을 없애고 장점을 강화시키기 위해 우리 조상들은 민간요법으로 소금을 대나무에 구워 사용하였는데 특히 풍치에 효과를 많이 보았으며, 소화가 안 될 때에도 사용하였다.In order to eliminate the disadvantages of salt and strengthen its strengths, our ancestors roasted salt on bamboo as a folk remedy.
통상적으로 죽염은 약성을 강화하기 위해 황토와 소나무를 이용하여 죽염 제조 시에 대나무의 죽력 성분과 황토와 소나무 불이 만나 발생하는 원적외선 등을 함유한 죽염이 개발되어 사용되고 있다.In general, bamboo salt is developed and used for bamboo salt containing far-infrared rays generated by meeting the tabasheer component of bamboo and ocher and pine fire in the manufacture of bamboo salt using ocher and pine to enhance its medicinal properties.
이러한 죽염의 제조 공정은 죽염 제조 시에 죽염의 자체 약성을 강화하는 것으로, 그 효과가 미비하고, 추가되는 성분도 제한적인 문제점이 있었다.The manufacturing process of bamboo salt is to strengthen the self-medication of bamboo salt when manufacturing bamboo salt, and the effect is insignificant, and the added ingredients are also limited.
이에 최근에는 건강에 이로운 다양한 성분을 부가하기 위해서는 건강에 이로운 기능성 성분을 혼합한 기능성 죽염이 개발되어 사용되고 있다.In recent years, in order to add various components beneficial to health, functional bamboo salt mixed with functional components beneficial to health has been developed and used.
그러나, 죽염에 혼합되는 기능성 물질은 분말 형태로 단순 혼합하게 되면 죽염과의 비중과 중량에 차이에 따라 한쪽으로 뭉치거나 균일하게 분포되지 못하여 죽염의 사용 시 기능성 물질이 불균일하게 함유되어 기능의 활성화가 되지 않는 문제점이 있었다.However, when the functional substances mixed with bamboo salt are simply mixed in powder form, they clump together on one side or are not uniformly distributed depending on the difference in specific gravity and weight with bamboo salt, so when using bamboo salt, functional substances are contained unevenly, resulting in activation of functions. There was a problem that didn't work.
또한, 기능성 물질은 천연성분의 경우에 분말로 제조하기 위해서 열풍으로 건조한 후에 분쇄하게 되면 물성이 변하여 특유 성분이 손상되어 활성화가 어려운 문제점이 있었다.In addition, in the case of natural ingredients, when dried with hot air and then pulverized in order to prepare them as powder, their physical properties change and the unique ingredients are damaged, making it difficult to activate them.
한편, 마늘은 외떡잎 식물 백합목 백합과의 여러해살이 풀을 말하는 것으로 특유의 냄새로 서구인들에게 멸시의 대상이었던 마늘이 최근에는 노화방지, 스테미너 항암작용에서 가장 우수한 식품으로 주목받고 있다.On the other hand, garlic refers to a perennial plant of the monocotyledonous plant Liliaceae Liliaceae, and garlic, which was despised by Westerners for its unique smell, is recently attracting attention as the best food for anti-aging and stamina anti-cancer activity.
마늘은 수세기 동안 음식물로서, 향신료와 의학적 소재로도 주요한 역할을 수행하여 왔다. 즉, 마늘(Allium sativm L)은 백합과(Lilliaceae) 파속(Allium)에 속하는 식물로써 예부터 향신료로 이용되어 왔을 뿐만 아니라, 약용으로도 널리 사용된다. 마늘 중에 약 0.3%∼0.4% 존재하는 알리신(allicin)은 그람(Gram) 양성균과 그람 음성균에 모두에 대하여 포자의 발아와 균의 생장을 억제하는 항균성을 가지며, 대사질환에 대한 약리작용도 있음이 보고되고 있으며, 또 극미량의 셀레늄(selenium)과 게르마늄(germanium)이 있어서 이들이 주로 항산화제 및 면역강화 역할과 항암 작용에 관여하며, 마늘의 유황성분은 다양한 예방 활성(chemopreventive activity)를 갖는다는 것이 보고된 바 있다.Garlic has played a major role as a food, spice and medicinal material for centuries. That is, garlic (Allium sativm L) is a plant belonging to the genus Allium of the family Lilliaceae and has been used as a spice since ancient times, and is also widely used for medicinal purposes. Allicin, which is present in about 0.3% to 0.4% of garlic, has antibacterial properties that inhibit spore germination and bacterial growth against both Gram-positive and Gram-negative bacteria, and also has pharmacological effects on metabolic diseases. In addition, it is reported that there are trace amounts of selenium and germanium, which are mainly involved in antioxidant and immune-enhancing roles and anti-cancer activity, and that the sulfur component of garlic has various chemopreventive activities. has been
또한, 최근의 연구에 의하면 마늘은 항미생물작용, 항균작용 및 혈액순환촉진작용 등이 있으며, 동맥경화(atherosclerosis), 하이퍼콜레스테르미아 (hypercholestermia), 알록산(alloxan) 의한 당뇨병 등과 같은 성인병에 대해서도 효과가 있는 것이 보고되어 있다.In addition, according to recent studies, garlic has antimicrobial action, antibacterial action, and blood circulation promoting action, and is effective against adult diseases such as atherosclerosis, hypercholestermia, and alloxan-induced diabetes. It has also been reported to be effective.
일반적으로 마늘은 수분 60%, 탄수화물 28%, 유기황화합물 2.3%, 단백질 2%, 유리 아미노산 1.2%, 섬유소 1.5%, 지방 0.15%, 소량의 피친산, 샤포닌 및 스토스테롤 등을 함유한다. 또한, 마늘은 비타민 A, B1, B2, C 등의 비타민 류와 칼슘, 칼륨, 구리, 아연, 게르마늄, 철, 마그네슘, 망간, 인, 황, 셀레늄 등의 무기물이 미량 함유되어 있다.In general, garlic contains 60% moisture, 28% carbohydrates, 2.3% organic sulfur compounds, 2% protein, 1.2% free amino acids, 1.5% fiber, 0.15% fat, and small amounts of phytic acid, saponin and testosterol. In addition, garlic contains trace amounts of vitamins such as vitamins A, B1, B2, and C, and minerals such as calcium, potassium, copper, zinc, germanium, iron, magnesium, manganese, phosphorus, sulfur, and selenium.
상기 마늘은 인체에 유익한 여러가지 성분이 내포되어 있는 유익한 식품이고 특히, 항암효과, 항균효과, 심장병 억제 효과, 스테미너, 노화방지, 근육증강, 피로회복, 해독작용에 유용한 것으로 알려져 있다.The garlic is a beneficial food containing various ingredients beneficial to the human body, and is known to be useful for anticancer effects, antibacterial effects, heart disease inhibitory effects, stamina, anti-aging, muscle enhancement, fatigue recovery, and detoxification.
그러나 이러한 방법은 대부분 가열에 의해 수분을 제거시키기 때문에 수분이 남거나, 혹은 마늘이 타거나 눌게 되어 저장성, 약용성분과 풍미성분의 변화가 야기되어 본래 마늘소금 복합소재로서의 기능을 일부 또는 전혀 발휘하지 못하게 된다. 또한, 가열단계를 거치는 추가 공정에 의해 원가의 상승과 대량생산에 한계가 있는 등 문제점도 있으며, 대부분 기술이 실제 실용화되지 못하고 있다.However, since most of these methods remove moisture by heating, moisture remains, or garlic is burned or pressed, causing changes in storage stability, medicinal components, and flavor components, which prevents some or all of the original functions as garlic salt composite materials. do. In addition, there are problems such as an increase in cost and a limitation in mass production due to an additional process that goes through a heating step, and most of the technologies have not been put into practical use.
이에 본 발명자들은 죽염에 마늘을 특정비율로 혼합시킴으로써 효능은 극대화시키고 풍미 및 맛을 향상시킴으로써 천연 조미료 및 기능성 천연식품으로 사용할 수 있는 마늘죽염을 개발함으로써 본 발명을 완성하였다.Accordingly, the present inventors completed the present invention by developing garlic bamboo salt that can be used as a natural seasoning and functional natural food by mixing bamboo salt with garlic at a specific ratio to maximize efficacy and improve flavor and taste.
따라서, 본 발명에서 해결하고자 하는 기술적 과제는 죽염에 마늘을 특정비율로 혼합시킴으로써 효능은 극대화시키고 풍미 및 맛을 향상시킨 마늘죽염의 제조방법을 제공하기 위한 것이다.Therefore, the technical problem to be solved by the present invention is to provide a method for producing garlic bamboo salt with maximized efficacy and improved flavor and taste by mixing garlic with bamboo salt in a specific ratio.
또한, 본 발명에서 해결하고자 하는 다른 기술적 과제는 상기 제조방법에 따라 제조된 마늘죽염을 제공하기 위한 것이다.In addition, another technical problem to be solved in the present invention is to provide garlic bamboo salt prepared according to the above manufacturing method.
상기한 기술적 과제를 해결하기 위하여, 본 발명에서는 죽염과 건마늘 분말을 9:1 내지 7:3의 중량비로 혼합하는 것을 특징으로 하는 마늘죽염의 제조방법을 제공한다.In order to solve the above technical problem, the present invention provides a method for producing garlic bamboo salt, characterized in that bamboo salt and dry garlic powder are mixed in a weight ratio of 9: 1 to 7: 3.
바람직하게, 상기 마늘죽염의 제조방법은 하기 단계를 포함하는 것을 특징으로 한다:Preferably, the method for preparing garlic bamboo salt is characterized by comprising the following steps:
(S1) 천일염을 이용하여 죽염을 제조하는 단계;(S1) preparing bamboo salt using sun salt;
(S2) 상기 단계 (S1)에서 제조된 죽염 물에 녹이고 건마늘 분말을 9:1 내지 7:3의 중량비로 혼합한 다음 진공상태하에서 35 내지 40℃에서 동결건조시켜 빙결정을 승화시키면서 수분을 제거하는 단계; 및 (S2) Dissolve in the bamboo salt water prepared in step (S1), mix dried garlic powder in a weight ratio of 9:1 to 7:3, and freeze-dry at 35 to 40 ° C. under vacuum to sublimate the ice crystals while removing moisture. removing; and
(S3) 상기 단계 (S2)에서 제조된 마늘죽염 빙결정을 40 내지 50메쉬의 크기로 분쇄하여 마늘죽염을 수득하는 단계.(S3) Grinding the garlic bamboo salt ice crystals prepared in step (S2) to a size of 40 to 50 mesh to obtain garlic bamboo salt.
바람직하게, 상기 죽염은 자죽염인 것을 특징으로 한다.Preferably, the bamboo salt is characterized in that bamboo salt.
바람직하게, 상기 자죽염은 다음 단계를 포함하는 방법에 따라 제조되는 것을 특징으로 한다:Preferably, the bamboo salt is characterized in that it is prepared according to a method comprising the following steps:
(1) 천일염을 대나무에 담고 황토로 입구를 막은 다음 1000 내지 2000 ℃ 온도의 장작불로 구워서 대나무는 모두 소실시키고 소금기둥만 남기는 단계; 및(1) putting bay salt in bamboo, covering the entrance with ocher, and roasting it over a wood fire at a temperature of 1000 to 2000 ° C to burn all the bamboo and leave only the salt pillar; and
(2) 상기 단계 (1)에서 남은 소금기둥을 잘게 부순 뒤 대나무통에 다시 넣고 상기 단계 (1)의 공정을 8회 더 반복한 다음 식혀서 자죽염을 수득하는 단계.(2) Crush the remaining salt column in step (1), put it back into the bamboo tube, repeat the process of step (1) 8 more times, and cool to obtain bamboo salt.
바람직하게, 상기 (2)의 마지막 굽는 공정에서 송진가루를 뿌려서 가열온도를 10 내지 20℃ 더 높여서 굽는 공정을 수행하는 것을 특징으로 한다.Preferably, in the last baking process of (2), the baking process is performed by sprinkling rosin powder and raising the heating temperature by 10 to 20 ° C.
상기한 다른 기술적 과제를 해결하기 위하여, 본 발명에서는 상기 제조방법에 따라 제조된 마늘죽염을 제공한다.In order to solve the above other technical problems, the present invention provides garlic bamboo salt prepared according to the above manufacturing method.
이와 같이, 본 발명에 따라 제조된 마늘죽염은 죽염과 마늘을 특정비율로 혼합함으로써 풍미와 맛 및 색감을 향상시켜 기호도를 증대시킬 수 있을 뿐만 아니라 유용한 성분인 페놀화합물의 함량을 증대시킴으로써 기능성을 증대시킬 수 있는 이점이 있다. 또한, 본 발명의 마늘죽염은 효능이 극대화되어 항산화 효과, 피로회복 효과, 소화개선 및 비만 방지 효과를 가지는 바, 천연조미료 또는 기능성 천연식품으로서 삶의 질을 향상시켜주는 웰빙 식품으로서 매우 유용하게 이용될 수 있을 것으로 기대된다.In this way, the garlic bamboo salt prepared according to the present invention can improve the flavor, taste and color by mixing bamboo salt and garlic in a specific ratio to increase the degree of preference, as well as increase the functionality by increasing the content of phenolic compounds, which are useful ingredients There are advantages to doing so. In addition, the garlic bamboo salt of the present invention has maximized efficacy and has antioxidant effects, fatigue recovery effects, digestion improvement and obesity prevention effects, so it is very useful as a well-being food that improves the quality of life as a natural seasoning or functional natural food. hopefully it can be
본 명세서에 첨부되는 다음의 도면들은 본 발명의 바람직한 실시예를 예시하는 것이며, 전술한 발명의 내용과 함께 본 발명의 기술사상을 더욱 이해시키는 역할을 하는 것이므로, 본 발명은 그러한 도면에 기재된 사항에만 한정되어 해석되어서는 아니 된다.
도 1은 본 발명에 따라 제조된 자죽염의 일례의 사진이다.The following drawings attached to this specification illustrate preferred embodiments of the present invention, and serve to further understand the technical idea of the present invention together with the contents of the above-described invention, so the present invention is limited to those described in the drawings. It should not be construed as limiting.
1 is a photograph of an example of bamboo salt prepared according to the present invention.
이하 본 발명을 좀더 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에서는 죽염과 건마늘 분말을 9:1 내지 7:3의 중량비로 혼합하는 것을 특징으로 하는 마늘죽염의 제조방법을 제공한다.The present invention provides a method for producing garlic bamboo salt, characterized in that bamboo salt and dried garlic powder are mixed in a weight ratio of 9: 1 to 7: 3.
본 발명의 하나의 구현예에 따르면, 상기 마늘죽염의 제조방법은 하기 단계를 포함하는 것을 특징으로 한다:According to one embodiment of the present invention, the method for preparing garlic bamboo salt is characterized by comprising the following steps:
(S1) 천일염을 이용하여 죽염을 제조하는 단계;(S1) preparing bamboo salt using sun salt;
(S2) 상기 단계 (S1)에서 제조된 죽염 물에 녹이고 건마늘 분말을 9:1 내지 7:3의 중량비로 혼합한 다음 진공상태하에서 35 내지 40℃에서 동결건조시켜 빙결정을 승화시키면서 수분을 제거하는 단계; 및 (S2) Dissolve in the bamboo salt water prepared in step (S1), mix dried garlic powder in a weight ratio of 9:1 to 7:3, and freeze-dry at 35 to 40 ° C. under vacuum to sublimate the ice crystals while removing moisture. removing; and
(S3) 상기 단계 (S2)에서 제조된 마늘죽염 빙결정을 40 내지 50메쉬의 크기로 분쇄하여 마늘죽염을 수득하는 단계.(S3) Grinding the garlic bamboo salt ice crystals prepared in step (S2) to a size of 40 to 50 mesh to obtain garlic bamboo salt.
상기 죽염과 건마늘 분말의 혼합비율은 9:1 내지 7:3의 중량비, 바람직하게는 8:2의 중량비일 수 있으며, 이 때 건마늘 분말의 중량이 죽염 9에 대하여 1보다 적을 경우 마늘죽염의 효능 극대화를 수득하기 어려우며, 건마늘 분말의 중량이 죽염 7에 대하여 3을 초과할 경우 마늘죽염에서 마늘의 맛이 너무 강하여 오히혀 기호도를 저하시킬 수 있다.The mixing ratio of the bamboo salt and dried garlic powder may be a weight ratio of 9:1 to 7:3, preferably a weight ratio of 8:2. At this time, if the weight of the dried garlic powder is less than 1 with respect to 9 bamboo salt, garlic bamboo salt It is difficult to obtain the maximum efficacy of, and if the weight of dried garlic powder exceeds 3 with respect to 7 of bamboo salt, the taste of garlic in garlic bamboo salt is too strong, which can rather reduce the preference.
본 발명의 하나의 구현예에 따르면, 상기 죽염은 일반적으로 사용되는 죽염으로서 특별히 제한되지 않으며, 1회 내지 9회의 굽는 공정을 거친 죽염이 모두 사용될 수 있다. According to one embodiment of the present invention, the bamboo salt is not particularly limited as generally used bamboo salt, and all bamboo salt that has undergone a baking process of 1 to 9 times can be used.
본 발명의 구체적인 실시양태에 따르면, 상기 죽염은 자죽염인 것을 특징으로 한다.According to a specific embodiment of the present invention, the bamboo salt is characterized in that it is bamboo salt.
상기 자죽염은 9회의 굽는 공정을 거쳐 제조된 죽염으로서 오행의 원소들이 골고루 집약된 결정체로 영롱하고 진한 보랏빛을 나타내는 것이 특징이다.The purple bamboo salt is bamboo salt prepared through a nine-time baking process, and is characterized by a bright and deep purple color as a crystal in which the elements of the five elements are evenly concentrated.
본 발명의 하나의 구현예에 따르면, 상기 자죽염은 다음 단계를 포함하는 방법에 따라 제조되는 것을 특징으로 한다:According to one embodiment of the present invention, the bamboo salt is characterized in that it is prepared according to a method comprising the following steps:
(1) 천일염을 대나무에 담고 황토로 입구를 막은 다음 1000 내지 2000 ℃ 온도의 장작불로 구워서 대나무는 모두 소실시키고 소금기둥만 남기는 단계; 및(1) putting bay salt in bamboo, covering the entrance with ocher, and roasting it over a wood fire at a temperature of 1000 to 2000 ° C to burn all the bamboo and leave only the salt pillar; and
(2) 상기 단계 (1)에서 남은 소금기둥을 잘게 부순 뒤 대나무통에 다시 넣고 상기 단계 (1)의 공정을 8회 더 반복한 다음 식혀서 자죽염을 수득하는 단계.(2) Crush the remaining salt column in step (1), put it back into the bamboo tube, repeat the process of step (1) 8 more times, and cool to obtain bamboo salt.
본 발명의 하나의 구현예에 따르면, 상기 (2)의 마지막 굽는 공정에서 송진가루를 뿌려서 가열온도를 10 내지 20℃ 더 높여서 굽는 공정을 수행하는 것을 특징으로 한다.According to one embodiment of the present invention, in the last baking step of (2), rosin powder is sprinkled and the heating temperature is raised by 10 to 20 ° C. to perform the baking step.
상기한 방법에 따라 제조된 자죽염은 자줏빛을 띠며, ??마그네슘, 철, 칼슘, 아연, 유황 등의 각종 미네랄이 다량 함유되어 있다.The purple bamboo salt prepared according to the above method has a purple color and contains a large amount of various minerals such as magnesium, iron, calcium, zinc, and sulfur.
한편, 본 발명에서는 상기 제조방법에 따라 제조된 마늘죽염을 제공한다.On the other hand, the present invention provides garlic bamboo salt prepared according to the above manufacturing method.
이와 같이, 본 발명에 따라 제조된 마늘죽염은 죽염과 마늘을 특정비율로 혼합함으로써 풍미와 맛 및 색감을 향상시켜 기호도를 증대시킬 수 있을 뿐만 아니라 유용한 성분인 페놀화합물의 함량을 증대시킴으로써 기능성을 증대시킬 수 있는 이점이 있다. 또한, 본 발명의 마늘죽염은 효능이 극대화되어 항산화 효과, 피로회복 효과, 소화개선 및 비만 방지 효과를 가지는 바, 천연조미료 또는 기능성 천연식품으로서 삶의 질을 향상시켜주는 웰빙 식품으로서 매우 유용하게 이용될 수 있을 것으로 기대된다.In this way, the garlic bamboo salt prepared according to the present invention can improve the flavor, taste and color by mixing bamboo salt and garlic in a specific ratio to increase the degree of preference, as well as increase the functionality by increasing the content of phenolic compounds, which are useful ingredients There are advantages to doing so. In addition, the garlic bamboo salt of the present invention has maximized efficacy and has antioxidant effects, fatigue recovery effects, digestion improvement and obesity prevention effects, so it is very useful as a well-being food that improves the quality of life as a natural seasoning or functional natural food. hopefully it can be
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다. Hereinafter, examples and the like will be described in detail to aid understanding of the present invention. However, the embodiments according to the present invention can be modified in many different forms, and the scope of the present invention should not be construed as being limited to the following examples. Embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
<실시예 1> 마늘죽염의 제조<Example 1> Preparation of garlic bamboo salt
천일염을 대나무에 담고 황토로 입구를 막은 다음 2000 ℃ 온도의 장작불로 구워서 죽염을 수득하였다.Bamboo salt was obtained by putting sun salt in bamboo, blocking the inlet with ocher, and roasting it over a wood fire at a temperature of 2000 ° C.
상기에서 수득한 죽염을 물에 녹이고 건마늘 분말을 8:2의 중량비로 혼합한 다음 진공상태 하에서 37℃에서 동결건조시켜 빙결정을 승화시키면서 수분을 제거하고, 마늘죽염 빙결정을 40 내지 50메쉬의 크기로 분쇄하여 마늘죽염을 수득하였다.Dissolve the bamboo salt obtained above in water, mix dry garlic powder at a weight ratio of 8:2, and freeze-dry it at 37 ° C. under vacuum to remove moisture while sublimating the ice crystals, and then remove the garlic bamboo salt ice crystals by 40 to 50 mesh Garlic bamboo salt was obtained by crushing to a size of.
<실시예 2> 마늘죽염의 제조<Example 2> Preparation of garlic bamboo salt
상기 죽염으로서 천일염을 대나무에 담고 황토로 입구를 막은 다음 2000 ℃ 온도의 장작불로 구워서 대나무는 모두 소실시키고 남은 소금기둥을 잘게 부순 뒤 대나무통에 다시 넣고 굽는 공정을 9회 반복하여 수득한 자죽염을 사용하는 것을 제외하고는 상기 실시예 1과 동일한 방법으로 마늘죽염을 제조하였다.As the bamboo salt, the bay salt is put in bamboo, the entrance is blocked with ocher, and the bamboo is burned over a wood fire at a temperature of 2000 ° C. The bamboo is all destroyed, and the remaining salt column is finely crushed, put back into the bamboo barrel, and the baking process is repeated 9 times. Garlic bamboo salt was prepared in the same manner as in Example 1 except for use.
이 때 상기 마지막 9번째 굽는 공정에서 송진가루를 뿌려서 가열온도를 15℃ 더 높여서 구워서 자주빛을 띠는 자죽염을 수득하였다.At this time, in the ninth baking step, rosin powder was sprinkled and the heating temperature was raised by 15 ° C. to obtain purple bamboo salt.
도 1은 본 발명에 따라 제조된 자죽염의 일례의 사진이다.1 is a photograph of an example of bamboo salt prepared according to the present invention.
<비교예 1> <Comparative Example 1>
죽염과 건마늘 분말의 중량비를 6:4로 하는 것을 제외하고는 상기 실시예 1과 동일한 방법으로 마늘죽염을 제조하였다.Garlic bamboo salt was prepared in the same manner as in Example 1, except that the weight ratio of bamboo salt and dried garlic powder was 6:4.
<비교예 2> <Comparative Example 2>
죽염과 건마늘 분말의 중량비를 9.5:0.5로 하는 것을 제외하고는 상기 실시예 1과 동일한 방법으로 마늘죽염을 제조하였다.Garlic bamboo salt was prepared in the same manner as in Example 1, except that the weight ratio of bamboo salt and dried garlic powder was 9.5: 0.5.
<비교예 3> <Comparative Example 3>
죽염이 아닌 소금을 사용하여 마늘소금을 제조하였다.Garlic salt was prepared using salt rather than bamboo salt.
<시험예 1> 마늘죽염의 일반성분 및 pH 측정<Test Example 1> Measurement of general components and pH of garlic bamboo salt
상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금에 대한 성분 및 품질조사 결과는 다음 표 1과 같다. 표 1에서 수분은 상압가열건조법, 총질소는 세미마이크로킬달법, 조지방은 속시렛추출법, 조회분은 건식회화법으로 측정하였다. pH는 시료에 10배량의 순수를 가하여 균질화한 후 pH 미터(Fisher Basic, USA)로써 측정하였다.The ingredients and quality investigation results for the garlic bamboo salt prepared in Examples 1 and 2, the garlic bamboo salt prepared in Comparative Examples 1 and 2, and the garlic salt prepared in Comparative Example 3 are shown in Table 1 below. In Table 1, moisture was measured by the atmospheric pressure drying method, total nitrogen by the semi-micro Kjeldahl method, crude fat by the Soxhlet extraction method, and crude ash by the dry ashing method. The pH was measured with a pH meter (Fisher Basic, USA) after homogenization by adding 10 times the amount of pure water to the sample.
상기 표 1에서 보듯이, 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금들의 수분 함량은 대체로 3% 내외로 비슷하였으며, 조회분의 함량은 비교예 3이 62.5%로 가장 많은 반면 본 발명의 실시예 1 및 2의 마늘죽염은 30.5%로 낮았으며, 비교예 1 및 2의 마늘죽염 시료들은 약 40% 정도로서 서로 비슷하였다. 이러한 함량조성의 차이는 마늘과 죽염의 배합 비율에 따라 달라질 수 있을 것으로 판단된다.As shown in Table 1, the moisture content of the garlic bamboo salt prepared in Examples 1 and 2, the garlic bamboo salt prepared in Comparative Examples 1 and 2, and the garlic salt prepared in Comparative Example 3 was similar at around 3%, The content of ash was the highest in Comparative Example 3 at 62.5%, whereas the garlic bamboo salt in Examples 1 and 2 of the present invention was low at 30.5%, and the garlic bamboo salt samples in Comparative Examples 1 and 2 were about 40%, similar to each other. . It is believed that the difference in content composition may vary depending on the mixing ratio of garlic and bamboo salt.
한편, pH는 실시예 1 및 2의 마늘죽염은 8.34 및 8.35로서 가장 높았는데, 이는 죽염의 pH가 9.35∼9.80으로 일반 소금에 비해 알칼리도가 높기 때문으로, 실시예 1 및 2에서 제조된 마늘죽염을 섭취할 경우 체질의 산성화 방지에도 상당히 도움을 줄 것으로 사료된다.On the other hand, the pH of the garlic bamboo salt of Examples 1 and 2 was the highest at 8.34 and 8.35, which is because the pH of the bamboo salt is 9.35 to 9.80, which is higher in alkalinity than ordinary salt, and the garlic bamboo salt prepared in Examples 1 and 2 is considered to be of great help in preventing acidification of the constitution.
<시험예 2> 마늘죽염의 색조 분석<Test Example 2> Color analysis of garlic bamboo salt
직시색차계(Nippon Denshoku, ZE-2000, Japan)를 사용하여 마늘죽염 시료의 색조에 대한 명도(lightness), 적색도(redness) 및 황색도(yellowness) 를 측정하였다. 이 때 색차계 표준백판의 색조는 명도= 96.82, 적색도= -0.38 및 황색도= 0.62이었다.Lightness, redness, and yellowness of garlic bamboo salt samples were measured using a direct vision colorimeter (Nippon Denshoku, ZE-2000, Japan). At this time, the color tone of the color difference meter standard white board was lightness = 96.82, redness = -0.38, and yellowness = 0.62.
시료 마늘죽염의 색조에 대하여 명도, 적색도 및 황색도를 직시색차계로 측정한 결과는 다음 표 2와 같다. The results of measuring the brightness, redness and yellowness of the sample garlic bamboo salt with a direct vision colorimeter are shown in Table 2 below.
상기 표 2에서 보듯이, 본 발명에서 제조한 실시예 1 및 2의 마늘죽염은 명도가 높았으며, 특히 실시예 2의 마늘죽염은 적색도와 황색도가 높은 것을 확인할 수 있었다.As shown in Table 2, the garlic bamboo salt of Examples 1 and 2 prepared in the present invention had high brightness, and in particular, the garlic bamboo salt of Example 2 had high redness and yellowness.
<시험예 3> 마늘죽염의 총 페놀화합물 함량 측정<Test Example 3> Measurement of total phenolic compound content of garlic bamboo salt
총 페놀화합물 함량은 폴린-데니스(Folin-Denis) 방법에 따라 분석하였다. 제조된 마늘죽염 시료액 1 mL에 증류수 3 mL를 넣고 Folin & Ciocalteau's 페놀 시약 1 mL를 첨가한 후 27℃ 쉐이킹배스(Shaking bath)에서 혼합하였다. 5분 후 NaCO3 포화용액 1 mL를 넣고 혼합하여 실온에서 1시간 방치한 후 640 nm에서 분광광도계(UV-1650PC, SHIMADZU)로 흡광도를 측정하였다. 페놀화합물 함량은 퀘르세틴, 클로로겐산, 탄닌산 및 카테킨의 농도를 이용하여 검량선을 작성한 다음 정량하였다.The total phenolic compound content was analyzed according to the Folin-Denis method. 3 mL of distilled water was added to 1 mL of prepared garlic bamboo salt sample solution, 1 mL of Folin &Ciocalteau's phenol reagent was added, and mixed in a 27 ° C. shaking bath. After 5 minutes, 1 mL of saturated NaCO 3 solution was added, mixed, left at room temperature for 1 hour, and absorbance was measured at 640 nm with a spectrophotometer (UV-1650PC, SHIMADZU). The content of phenolic compounds was quantified after preparing a calibration curve using the concentrations of quercetin, chlorogenic acid, tannic acid and catechin.
상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금의 총 페놀화합물 함량을 하기 표 3에 나타내었다. The total phenolic compound contents of the garlic bamboo salt prepared in Examples 1 and 2, the garlic bamboo salt prepared in Comparative Examples 1 and 2, and the garlic salt prepared in Comparative Example 3 are shown in Table 3 below.
상기 표 3에서 알 수 있는 바와 같이, 본 발명의 실시예 1 및 2의 마늘죽염의 총 페놀화합물 함량은 비교예 1 및 2에서 제조된 마늘죽염 및 비교예 3에서 제조한 마늘소금에 비하여 월등하게 높게 나타났다. As can be seen from Table 3, the total phenolic compound content of garlic bamboo salt of Examples 1 and 2 of the present invention is significantly higher than that of garlic bamboo salt prepared in Comparative Examples 1 and 2 and garlic salt prepared in Comparative Example 3 appeared high.
이로부터, 죽염에 건마늘을 특정비율로 혼합시킴으로써 유효성분의 함량을 최대화하는 상승효과를 수득하였음을 확인할 수 있었다.From this, it was confirmed that a synergistic effect of maximizing the content of the active ingredient was obtained by mixing dried garlic with bamboo salt in a specific ratio.
<시험예 4> 마늘죽염의 항산화 효과 측정<Test Example 4> Measurement of antioxidant effect of garlic bamboo salt
(1) 알코올 탈수소효소(Alcohol dehydrogenase, ADH)의 활성도 측정(1) Measuring the activity of alcohol dehydrogenase (ADH)
ADH 활성도는 분광광도계를 이용하여 340㎚에서 형성되는 NADH의 흡광도를 측정하여 활성도를 표시하였다. 즉 반응액의 조성은 증류수 1.4 ㎖, 에탄올 0.3 ㎖, 20mM NAD+ 수용액 0.3㎖, 각각의 샘플을 0.1㎖를 첨가하고 1.0 M Tris-Hcl buffer 용액(pH 8.8)을 0.75 ㎖ 첨가하여 총부피가 2.85 ㎖이 되도록 첨가한 후, 25℃ 항온조에서 10분간 반응시키고, ADH(5unit/㎖) 0.15㎖를 가하여 반응용량이 3㎖이 되도록 조절하여 25℃에서 3분간 예비배양하고 5분 동안 340㎚에서 흡광도의 변화를 측정하였으며, 이 때 대조군은 증류수를 사용하였다.ADH activity was indicated by measuring the absorbance of NADH formed at 340 nm using a spectrophotometer. That is, the composition of the reaction solution was 1.4 ml of distilled water, 0.3 ml of ethanol, 0.3 ml of 20mM NAD + aqueous solution, 0.1 ml of each sample, and 0.75 ml of 1.0 M Tris-Hcl buffer solution (pH 8.8) was added to obtain a total volume of 2.85 ml. After addition, the reaction was performed in a thermostat at 25 ° C for 10 minutes, 0.15 mL of ADH (5 unit / mL) was added to adjust the reaction volume to 3 mL, pre-incubation at 25 ° C for 3 minutes, and absorbance at 340 nm for 5 minutes. Changes were measured, and at this time, distilled water was used as a control group.
ADH 활성은 반응 종료시 최대 흡광도를 대조군의 최대 흡광도에 대한 비율로 나타내었으며, 다음과 같은 수학식 1로 계산하였으며, 그 결과는 하기 표 4에 나타내었다.ADH activity was expressed as a ratio of the maximum absorbance at the end of the reaction to the maximum absorbance of the control group, and was calculated by Equation 1 below, and the results are shown in Table 4 below.
(A : 대조군의 최대 흡광도, B : 실험구의 최대 흡광도)(A: maximum absorbance of the control group, B: maximum absorbance of the experimental group)
상기 표 4에서 보듯이, ADH에 대한 활성을 측정한 결과, 본 발명의 실시예 1 및 2의 마늘죽염은 189.98% 및 192.15%의 최대 활성을 보여 비교예 1 내지 3에 비하여 매우 높은 활성을 나타냈다.As shown in Table 4, as a result of measuring the activity against ADH, the garlic bamboo salt of Examples 1 and 2 of the present invention showed the maximum activity of 189.98% and 192.15%, showing very high activity compared to Comparative Examples 1 to 3 .
(2) 알데하이드 탈수소효소(Acetaldehyde dehydrogenase, ALDH)의 활성도 측정(2) Measuring the activity of aldehyde dehydrogenase (ALDH)
ALDH의 활성도는 NADH 생성에 따른 흡광도의 변화를 340㎚에서 측정하였다. ALDH의 활성도 측정을 위해 증류수 2.1 mL, 1.0 M Tris-HCl buffer(pH 8.0), 0.3 mL, 20 mM NAD+ 0.1 mL, 0.1 M acetaldehyde 0.1 mL, 3.0 M KCl 0.1 mL, 0.33 M 2-mercaptoethanol 0.1 mL, 시료 0.1 mL를 혼합한 후, 25℃에서 10분간 반응시키고 ALDH (1 unit/ml) 0.1 mL를 첨가한 후, 반응용액이 3 mL이 되도록 조절하여 cuvette에 넣고 25℃에서 5분간 예비 배양한 후, 5분간 340 nm에서 흡광도의 변화를 측정하였으며, 이 때 대조군은 증류수를 사용하였다.As for the activity of ALDH, the change in absorbance according to NADH production was measured at 340 nm. For the measurement of ALDH activity, distilled water 2.1 mL, 1.0 M Tris-HCl buffer (pH 8.0), 0.3 mL, 20 mM NAD+ 0.1 mL, 0.1 M acetaldehyde 0.1 mL, 3.0 M KCl 0.1 mL, 0.33 M 2-mercaptoethanol 0.1 mL, After mixing 0.1 mL of the sample, react at 25 ° C for 10 minutes, add 0.1 mL of ALDH (1 unit / ml), adjust the reaction solution to 3 mL, put it in a cuvette, pre-incubate at 25 ° C for 5 minutes, and , The change in absorbance was measured at 340 nm for 5 minutes, at which time distilled water was used as a control group.
ALDH 활성 계산식은 다음과 같은 수학식 2로 계산하였으며, 그 결과는 하기 표 5에 나타내었다.The ALDH activity calculation formula was calculated by the following Equation 2, and the results are shown in Table 5 below.
(A : 대조군의 최대 흡광도, B : 실험구의 최대 흡광도)(A: maximum absorbance of the control group, B: maximum absorbance of the experimental group)
상기 표 5에서 보듯이, ALDH에 대한 활성을 측정한 결과, 본 발명의 실시예 1 및 2의 마늘죽염은 165.91% 및 168.22%의 최대 활성을 보여 비교예 1 내지 3에 비하여 매우 높은 활성을 보이는 것으로 나타났다.As shown in Table 5, as a result of measuring the activity for ALDH, the garlic bamboo salt of Examples 1 and 2 of the present invention showed the maximum activity of 165.91% and 168.22%, showing very high activity compared to Comparative Examples 1 to 3 appeared to be
<시험예 5> 마늘죽염의 숙취해소 효과 평가<Test Example 5> Evaluation of hangover relief effect of garlic bamboo salt
월 1회 이상 숙취로 인한 업무 곤란 경험이 있는 남녀 직장인(60명, 남녀 비율 2:1, 25~58세)을 대상으로 숙취 해소에 도움이 되는 정도를 평가하였다. 대조군으로 마늘죽염을 섭취하지 않은 경우로 하여 진행하였다.Male and female office workers (60 persons, male to female ratio: 2:1, 25-58 years old) who had experience of work difficulties due to hangovers at least once a month were evaluated on the degree of help in relieving hangovers. As a control group, a case where garlic bamboo salt was not consumed was used.
평가를 위하여, 각 직장인을 4개의 군(n=15)으로 나누고 오후 7시에서 11시 사이에 상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금을 섭취하게 한 후, 평상시 숙취를 일으키는 각자의 주량의 1.5배를 소비하게 하였다. For evaluation, each office worker was divided into 4 groups (n = 15) and compared with garlic bamboo salt prepared in Examples 1 and 2 and garlic bamboo salt prepared in Comparative Examples 1 and 2 between 7:00 and 11:00 pm. After ingesting the garlic salt prepared in Example 3, they consumed 1.5 times the amount of alcohol that usually causes a hangover.
다음날 저녁 식사 전까지의 경험에 의거하여 마늘죽염 섭취가 평상시에 비해 숙취 해소에 도움이 된 정도를 하기 표 6에 5점 타점법(5점 : 아주 우수함, 4점 : 우수함, 3점 : 보통, 2점 : 나쁨, 1점 : 아주나쁨)으로 나타내게 하였다. Based on the experience before dinner the next day, the degree to which the intake of garlic bamboo salt was more helpful in relieving hangover than usual was scored using the 5-point scoring method in Table 6 below (5 points: very good, 4 points: excellent, 3 points: normal, 2 points) Point: bad, 1 point: very bad).
상기 표 6에서 보듯이, 본 발명의 실시예 1 및 2의 마늘죽염을 복용한 직장인의 경우 비교예 1 및 2에서 제조된 마늘죽염 및 비교예 3에서 제조한 마늘소금을 복용한 경우에 비하여 숙취해소 효과가 월등하게 우수하였다. As shown in Table 6, office workers who took the garlic bamboo salt of Examples 1 and 2 of the present invention had a hangover compared to those who took the garlic bamboo salt prepared in Comparative Examples 1 and 2 and the garlic salt prepared in Comparative Example 3. The dissolving effect was remarkably excellent.
이어서, 상기 숙취해소 효과 시험에 이어 본 발명의 마늘죽염에 대한 두통, 울렁거림, 구역질 및 구토, 식욕부진, 발열, 속쓰림 및 불면증에 대한 평가를 실시하였다.Subsequently, following the hangover relief effect test, the garlic bamboo salt of the present invention was evaluated for headache, nausea, nausea and vomiting, anorexia, fever, heartburn and insomnia.
관능검사 요원을 대상으로 두통, 울렁거림, 구역질 및 구토, 식욕부진, 발열, 속쓰림 및 불면증에 대한 검사를 3회 반복하여 실시하였다. Headache, nausea, vomiting, anorexia, fever, heartburn, and insomnia were repeated three times for sensory test personnel.
검사 방법으로는 5점 비교 척도법을 사용하였으며, 아주 좋다는 5점, 좋다 는 4점, 보통이다는 3점, 싫다는 2점, 아주 싫다는 1점의 점수를 각각 부여하고, 최종 응답된 점수를 합하여 산술평균 값을 연산하였다. 대조군으로 마늘죽염을 복용하지 않은 경우로 하여 진행하였다. 그 결과는 하기 표 7에 나타내었다. As a test method, a 5-point comparison scale method was used, and 5 points for very good, 4 points for good, 3 points for average, 2 points for dislike, and 1 point for very dislike were assigned, respectively, and the final response score was The arithmetic mean value was calculated by summing. As a control group, garlic bamboo salt was not taken. The results are shown in Table 7 below.
상기 표 7에서 보듯이, 두통, 울렁거림, 구역질 및 구토, 식욕부진, 발열, 속쓰림 및 불면증에 대한 평가에서 실시예 1 및 2에서 제조된 마늘죽염이 현격하게 우수한 평가를 받았다. As shown in Table 7, the garlic bamboo salt prepared in Examples 1 and 2 received a remarkably excellent evaluation in the evaluation of headache, nausea, nausea and vomiting, anorexia, fever, heartburn and insomnia.
<시험예 6> 소화기능 및 피로회복 개선 효과 확인<Test Example 6> Confirmation of digestive function and fatigue recovery improvement effect
상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금을 각 군별로 5명씩 10~40대의 남녀노소 20명에게 30일간, 매일 하루 3번 110㎖씩 점심식사 후 2시간 후에 복용하게 하였으며, 30일간의 복용 후, 소화기능 개선 및 피로감 개선 정도를 하기 표 8에 5점 타점법(5점 : 아주 우수함, 4점 : 우수함, 3점 : 보통, 2점 : 나쁨, 1점 : 아주나쁨)으로 나타내게 하였다. Garlic bamboo salt prepared in Examples 1 and 2, garlic bamboo salt prepared in Comparative Examples 1 and 2, and garlic salt prepared in Comparative Example 3 were given to 20 men and women in their 10s to 40s, 5 people from each group for 30 days, 110 ml 3 times a day was taken 2 hours after lunch, and after taking 30 days, the degree of improvement in digestive function and fatigue was scored according to the 5-point scoring method in Table 8 below (5 points: very good, 4 points: excellent , 3 points: average, 2 points: bad, 1 point: very bad).
개선 효과digestive function
improvement effect
개선 효과Fatigue
improvement effect
상기 표 8에서 보듯이, 본 발명의 실시예 1 및 2의 마늘죽염은 비교예 1 내지 3에 비하여 소화기능 및 피로감 개선 효과가 매우 우수하였다. 특히 점심식사 후 섭취시 소화기능이 개선되어 속이 거북하거나 하는 증상 없이 편안하였으며, 피로감이 개선되어 오후에 공부 또는 일에 보다 집중할 수 있었다고 평가하였다.As shown in Table 8, the garlic bamboo salt of Examples 1 and 2 of the present invention was very excellent in digestive function and fatigue improvement effect compared to Comparative Examples 1 to 3. In particular, it was evaluated that digestive function was improved when taken after lunch, and it was comfortable without symptoms of upset stomach, and fatigue was improved, so that it was possible to concentrate more on study or work in the afternoon.
<시험예 7> 체중 및 혈중 콜레스테롤 감소 실험<Test Example 7> Body weight and blood cholesterol reduction test
실험동물로 ICR 마우스를 이용하여, 상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금을 재료로 한 시험대조군과 정상군을 식이 급여하며 사육 비교하였다.A test control group and a normal group using ICR mice as experimental animals, using garlic bamboo salt prepared in Examples 1 and 2, garlic bamboo salt prepared in Comparative Examples 1 and 2, and garlic salt prepared in Comparative Example 3 as ingredients. were fed and compared with breeding.
본 실험에서 기본 식이는 AIN-76을 기본으로 단백질급원은 카제인(Japan), 탄수화물급원은 옥수수전분(제일제당), 지방급원으로 옥수수유(대상)을 사용한 정상군과 시험대조군을 비교하는 방식으로 진행하였다. 본 실험에 사용한 마늘죽염은 매일 일정시간에 1 ml씩 경구 급여하였으며 식이와 식수는 임의로 자유롭게 섭취하도록 하였다. 시험동물 사육환경은 항온(20±2℃), 항습(50±5%)하고 12 시간 광주기로 일정 조건을 유지하면서 폴리카보네이트 케이지에서 2 마리씩 분리하여 사육하였다. 동물에서 콜레스테롤은 혈류를 따라 순환하며 몇몇 기관에서 합성되며 혈류 내에서 콜레스테롤 수치가 크면 동맥경화의 주요 원인이 되므로 분석항목은 (1) 체중변화 및 식이섭취량, (2) 혈중 콜레스테롤 및 중성지질을 측정하는 것으로 진행하였다. In this experiment, the basic diet was AIN-76, the protein source was casein (Japan), the carbohydrate source was corn starch (CheilJedang), and the fat source was corn oil (subject). proceeded. Garlic bamboo salt used in this experiment was orally fed by 1 ml every day at a certain time, and food and drinking water were freely consumed. The test animal breeding environment was kept at constant temperature (20 ± 2 ° C), constant humidity (50 ± 5%), and kept at constant conditions with a 12-hour photoperiod, while breeding by separating two animals in a polycarbonate cage. In animals, cholesterol circulates along the bloodstream and is synthesized in several organs, and high cholesterol levels in the bloodstream are the main cause of arteriosclerosis. Therefore, analysis items are (1) weight change and dietary intake, (2) blood cholesterol and triglyceride proceeded to do.
사육이 끝난 실험동물은 12 시간 절식시킨 후 에테르(Ether)를 흡입시켜 마취시킨 다음 복부 하대정맥으로부터 채혈하였으며, 헤파린을 처리하여 원심분리(15 mins, 3,000 RPM)로 혈장을 분리하여 지질함량을 측정하였다.After breeding, the experimental animals were fasted for 12 hours, anesthetized by inhalation of ether, blood was collected from the inferior vena cava, treated with heparin, and plasma was separated by centrifugation (15 mins, 3,000 RPM) to measure lipid content. did
각 실험동물의 내장(간, 부고환, 신장)을 혈액채취 후 즉시 적출하여 PBS(Phosphate Buffered saline) 용액으로 수차례 헹군 후 표면 수분을 제거하여 비교 정량하였다. 혈장 중성지질은 McGowan 등(1983)의 효소법을 이용한 발색방식의 중성지방 측정용 시액(Asan kit)를 사용하여 550 nm에서 흡광도를 측정하였으며, 혈장 총 콜레스테롤은 Allain 등(1974)의 효소법을 응용한 총콜레스테롤 측정용 시액(Asan kit)를 사용하여 발색처리하여 500 nm에서 흡광도를 측정하여 이를 콜레스테롤 표준곡선과 비교 정량하는 방식으로 하였으며, 장기의 지질은 Folch 등(1957)의 방법으로 잘게 자른 후 2 ml, Chloroform: Methyl alcohol 2:1 용액하에서 추출하여 중성지질, 콜레스테롤은 혈장에서와 동일 방법으로 정량하였다. 각 항목은 통계처리하여 평균값으로 하였다. The intestines (liver, epididymis, kidney) of each experimental animal were removed immediately after blood collection, rinsed several times with a PBS (Phosphate Buffered saline) solution, and then surface moisture was removed for comparative quantification. Plasma triglyceride was measured for absorbance at 550 nm using the assay (Asan kit) for triglyceride measurement using the enzymatic method of McGowan et al. (1983), and plasma total cholesterol was measured using the enzymatic method of Allain et al. The total cholesterol measurement solution (Asan kit) was used for color development, and the absorbance was measured at 500 nm, and the result was compared and quantified with the cholesterol standard curve. ml, Chloroform: Extracted under a 2:1 solution of methyl alcohol, and triglyceride and cholesterol were quantified in the same way as in plasma. Each item was statistically processed and averaged.
(1) 체중변화(1) Weight change
실험동물의 체중변화 및 식이섭취량을 하기 표 9 및 10에 각각 나타내었다. Changes in body weight and food intake of the experimental animals are shown in Tables 9 and 10, respectively.
하기 표 9를 참조하면, 실시예 1 및 2로부터 제조된 마늘죽염을 경구 급여한 실험동물의 경우 실험전에 비하여 체중이 유사 또는 저하되었고, 반면 비교예 1 내지 4로부터 제조된 마늘죽염을 경구 급여한 실험동물 및 정상군의 경우 실험전에 비하여 체중이 증가했음을 확인할 수 있다.Referring to Table 9 below, in the case of experimental animals orally fed garlic bamboo salt prepared from Examples 1 and 2, the body weight was similar or decreased compared to before the experiment, while orally fed garlic bamboo salt prepared from Comparative Examples 1 to 4. In the case of the experimental animals and the normal group, it can be confirmed that the body weight has increased compared to before the experiment.
하기 표 10을 참조하면, 상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금을 경구 급여한 실험동물 및 정상군의 식이섭취량은 모두 유사한 것으로 확인하였다.Referring to Table 10 below, the diet of experimental animals and normal groups orally fed garlic bamboo salt prepared in Examples 1 and 2, garlic bamboo salt prepared in Comparative Examples 1 and 2, and garlic salt prepared in Comparative Example 3 The intake was confirmed to be similar for all.
이를 통하여 모든 실험동물의 식이 섭취량이 유사함에도 불구하고, 실시예 1 및 2의 마늘죽염을 섭취한 실험동물의 체중이 모두 증가하지 않고, 실험 전과 유사하거나 실험전에 비하여 감소하여 기능성 식품으로서 활용 가능함을 확인하였다.Through this, despite the similar dietary intake of all the experimental animals, the body weight of the experimental animals consuming the garlic bamboo salt of Examples 1 and 2 did not increase, and was similar to before the experiment or decreased compared to before the experiment, indicating that it can be used as a functional food. Confirmed.
(2) 혈중 콜레스테롤 및 중성지질(2) Blood cholesterol and triglyceride
실험동물의 혈장 중성지질, 혈장 콜레스테롤, 부고환 중성지질, 신장 조직의 중성지질 및 간조직에서의 콜레스테롤을 하기 표 11 및 12에 나타내었다.Plasma triglyceride, plasma cholesterol, epididymal triglyceride, kidney tissue neutral lipid, and cholesterol in liver tissue of experimental animals are shown in Tables 11 and 12 below.
하기 표 11을 참조하면, 실시예 1 및 2의 마늘죽염을 섭취한 시험대조군은 실험전에 비해 혈장 중성지질이 현저히 감소한 반면, 비교예 1 내지 3의 마늘죽염 및 마늘소금을 섭취한 시험대조군은 유의적인 변화가 나타나지 않았다.Referring to Table 11 below, the test control group ingesting garlic bamboo salt of Examples 1 and 2 showed a significant decrease in plasma triglyceride compared to before the experiment, whereas the test control group ingesting garlic bamboo salt and garlic salt in Comparative Examples 1 to 3 showed significant No significant changes were observed.
하기 표 12를 참조하면, 실시예 1 및 2의 마늘죽염을 섭취한 시험대조군은 실험전에 비해 혈장 콜레스테롤이 현저히 감소한 반면, 비교예 1 내지 3은 유의적인 변화가 나타나지 않았음을 확인할 수 있다.Referring to Table 12 below, it can be seen that the test control group ingesting the garlic bamboo salt of Examples 1 and 2 significantly reduced plasma cholesterol compared to before the experiment, while Comparative Examples 1 to 3 showed no significant change.
상기 결과를 통하여, 본 발명에 따른 실시예 1 및 2에서 제조된 마늘죽염은 중성지질의 양의 감소현상을 확인할 수 있어 지방과 콜레스테롤을 개선시키는 특징을 확인하였다. Through the above results, garlic bamboo salt prepared in Examples 1 and 2 according to the present invention was able to confirm the decrease in the amount of neutral lipids, confirming the feature of improving fat and cholesterol.
<시험예 8> 마늘죽염의 관능 평가<Test Example 8> Sensory evaluation of garlic bamboo salt
상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금에 대한 기호도를 조사하기 위하여 다음과 같이 관능 평가를 실시하였다. In order to investigate the acceptability of garlic bamboo salt prepared in Examples 1 and 2, garlic bamboo salt prepared in Comparative Examples 1 and 2, and garlic salt prepared in Comparative Example 3, sensory evaluation was performed as follows.
관능검사 요원 25명을 대상으로 향, 맛, 색감, 외관 및 전체적인 기호도에 대한 관능검사를 3회 반복하여 하기 표 13과 같은 결과를 얻었다. The sensory test for aroma, taste, color, appearance, and overall acceptability was repeated three times for 25 sensory test agents, and the results shown in Table 13 were obtained.
검사 방법으로는 5점 비교 척도법을 사용하였으며, 아주 좋다는 5점, 좋다 는 4점, 보통이다는 3점, 싫다는 2점, 아주 싫다는 1점의 점수를 각각 부여하고, 최종 응답된 점수를 합하여 산술평균값을 연산하였다. As a test method, a 5-point comparison scale method was used, and 5 points for very good, 4 points for good, 3 points for average, 2 points for dislike, and 1 point for very dislike were assigned, respectively, and the final response score was The arithmetic mean value was calculated by summing.
상기 표 13에서 보듯이, 실시예 1 및 2에서 제조된 마늘죽염은 비교예 1 내지 3에 비하여 향, 맛, 색감, 외관 및 전체적인 기호도가 매우 높게 나타났다. As shown in Table 13, the garlic bamboo salt prepared in Examples 1 and 2 showed very high aroma, taste, color, appearance and overall preference compared to Comparative Examples 1 to 3.
<시험예 9> 마늘죽염의 미생물 검출 시험<Test Example 9> Microbial detection test of garlic bamboo salt
상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금을 7~10℃ 냉장조건에서 보관하면서 1달 간격으로 시료를 채취하여 미생물 품질변화를 조사하였다.Garlic bamboo salt prepared in Examples 1 and 2, garlic bamboo salt prepared in Comparative Examples 1 and 2, and garlic salt prepared in Comparative Example 3 were stored at 7 to 10 ° C. refrigerated conditions, and samples were taken at intervals of one month Microbial quality changes were investigated.
미생물 검출 분석은 미생물 확인시험은 식품공전에 준하는 표준 방법으로 수행하였으며, 품질관리 항목인 총균수, 대장균군, 황색포도상구균 총 3가지에 대한 미생물 항목을 시험 확인하였다. 시료 10g과 멸균된 생리식염수(0.85%) 90ml을 미생물 시료 균질기 백(Stomacher bag)에 담고 미생물 시료 균질기를 이용하여 균질화시킨 후 시험액으로 사용하였고, 이 시험액 1ml을 3M사의 페트리필름지에 분주하여 Incubator (37±1℃)에서 24시간 동안 배양한 후 콜로니 형성 균체를 계수한 후 2~3회 반복치의 평균값을 이용하여 시료 g당 세균수 (CFU/g)로 표시하였다. 그 결과는 하기 표 14에 나타내었다. Microbial detection analysis was carried out according to the standard method according to the Food Code, and microbial items for a total of three quality control items, total number of bacteria, coliform group, and Staphylococcus aureus, were tested and confirmed. 10 g of sample and 90 ml of sterilized physiological saline (0.85%) were placed in a microbial sample homogenizer bag, homogenized using a microbial sample homogenizer, and used as a test solution. After culturing at (37±1° C.) for 24 hours, colony-forming cells were counted, and the average value of 2 to 3 repetitions was used to express the number of bacteria per gram of sample (CFU/g). The results are shown in Table 14 below.
상기 표 14에 나타낸 바와 같이, 2달 저장 후 총균수는 실시예 1 및 2의 마늘죽염의 경우 1.8x10 CFU/g 및 1.8x10 CFU/g로 낮았으며, 대장균군과 황색포도상구균은 모든 시료에서 검출되지 않았다. As shown in Table 14, the total number of bacteria after 2 months of storage was as low as 1.8x10 CFU/g and 1.8x10 CFU/g in the case of garlic bamboo salt of Examples 1 and 2, and coliforms and Staphylococcus aureus were found in all samples. Not detected.
<시험예 10> 마늘죽염을 사용한 육류의 관능 평가<Test Example 10> Sensory evaluation of meat using garlic bamboo salt
상기 실시예 1 및 2에서 제조한 마늘죽염 및 비교예 1 및 2에서 제조된 마늘죽염과, 비교예 3에서 제조한 마늘소금을 이용하여 소고기를 구워서 관능검사를 수행하였다. 상기 각 구워진 소고기의 관능평가를 수행하였다.The sensory test was performed by roasting beef using garlic bamboo salt prepared in Examples 1 and 2, garlic bamboo salt prepared in Comparative Examples 1 and 2, and garlic salt prepared in Comparative Example 3. Sensory evaluation of each of the grilled beef was performed.
본 식품의 관능적 식별 능력이 있는 관능검사요원 25명을 선정하여 관능적 품질의 평가 척도는 9점 채점법(9점: 아주 좋다, 7점: 좋다, 5점: 보통이다, 3점: 조금 나쁘다, 1점: 아주 나쁘다)으로 하였다. 관능검사 결과는 ANOVA를 이용하여 5% 수준에서 Duncan's multiple range test에 의해 각 시료간의 유의적인 차이를 검증하였다. 그 결과는 하기 표 15(평균값)에 나타내었다. 25 sensory inspectors with sensory identification ability of this food were selected and the sensory quality evaluation scale was 9-point scoring method (9 points: very good, 7 points: good, 5 points: normal, 3 points: slightly bad, 1 Point: very bad). The sensory test results were verified for significant differences between each sample by Duncan's multiple range test at the 5% level using ANOVA. The results are shown in Table 15 (average values) below.
상기 표 15에서 보듯이, 본 발명에 따라 제조된 마늘죽염을 이용하여 소고기를 구운 경우 색, 맛 및 향에서 우수한 평가를 받았으며, 특히 육류의 잡내가 거의 완벽하게 제거되어 전반적인 기호도 평가에서 매우 우수한 평가를 받았다. As shown in Table 15, when beef was grilled using garlic bamboo salt prepared according to the present invention, it was evaluated excellently in color, taste and aroma, and in particular, it was almost completely removed from the meat, giving a very good evaluation in the overall preference evaluation. received
이상으로 본 발명의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.Having described specific parts of the present invention in detail above, it is clear that these specific techniques are only preferred embodiments for those skilled in the art, and the scope of the present invention is not limited thereto. Accordingly, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
Claims (6)
하기 단계를 포함하는 것을 특징으로 하는 마늘죽염의 제조방법:
(S1) 천일염을 이용하여 죽염을 제조하는 단계;
(S2) 상기 단계 (S1)에서 제조된 죽염 물에 녹이고 건마늘 분말을 9:1 내지 7:3의 중량비로 혼합한 다음 진공상태하에서 35 내지 40℃에서 동결건조시켜 빙결정을 승화시키면서 수분을 제거하는 단계; 및
(S3) 상기 단계 (S2)에서 제조된 마늘죽염 빙결정을 40 내지 50메쉬의 크기로 분쇄하여 마늘죽염을 수득하는 단계.According to claim 1,
A method for producing garlic bamboo salt comprising the following steps:
(S1) preparing bamboo salt using sun salt;
(S2) Dissolve in the bamboo salt water prepared in step (S1), mix dried garlic powder in a weight ratio of 9:1 to 7:3, and freeze-dry at 35 to 40 ° C. under vacuum to sublimate the ice crystals while removing moisture. removing; and
(S3) Grinding the garlic bamboo salt ice crystals prepared in step (S2) to a size of 40 to 50 mesh to obtain garlic bamboo salt.
상기 죽염은 자죽염인 것을 특징으로 하는 마늘죽염의 제조방법.According to claim 1,
The method for producing garlic bamboo salt, characterized in that the bamboo salt is bamboo salt.
상기 자죽염은 다음 단계를 포함하는 방법에 따라 제조되는 것을 특징으로 하는 마늘죽염의 제조방법:
(1) 천일염을 대나무에 담고 황토로 입구를 막은 다음 1000 내지 2000 ℃ 온도의 장작불로 구워서 대나무는 모두 소실시키고 소금기둥만 남기는 단계; 및
(2) 상기 단계 (1)에서 남은 소금기둥을 잘게 부순 뒤 대나무통에 다시 넣고 상기 단계 (1)의 공정을 8회 더 반복한 다음 식혀서 자죽염을 수득하는 단계.According to claim 1,
The method for producing garlic bamboo salt, characterized in that the bamboo salt is prepared according to a method comprising the following steps:
(1) putting bay salt in bamboo, covering the entrance with ocher, and roasting it over a wood fire at a temperature of 1000 to 2000 ° C to burn all the bamboo and leave only the salt pillar; and
(2) Crush the remaining salt column in step (1), put it back into the bamboo tube, repeat the process of step (1) 8 more times, and cool to obtain bamboo salt.
상기 (2)의 마지막 굽는 공정에서 송진가루를 뿌려서 가열온도를 10 내지 20℃ 더 높여서 굽는 공정을 수행하는 것을 특징으로 하는 마늘죽염의 제조방법.According to claim 4,
Method for producing garlic bamboo salt, characterized in that in the last baking step of (2), the baking step is performed by sprinkling pine powder and raising the heating temperature by 10 to 20 ° C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210062474A KR20220154923A (en) | 2021-05-14 | 2021-05-14 | A process for the preparation of garlic bamboo salt and the garlic bamboo salt prepared therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210062474A KR20220154923A (en) | 2021-05-14 | 2021-05-14 | A process for the preparation of garlic bamboo salt and the garlic bamboo salt prepared therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220154923A true KR20220154923A (en) | 2022-11-22 |
Family
ID=84236454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210062474A KR20220154923A (en) | 2021-05-14 | 2021-05-14 | A process for the preparation of garlic bamboo salt and the garlic bamboo salt prepared therefrom |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220154923A (en) |
-
2021
- 2021-05-14 KR KR1020210062474A patent/KR20220154923A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
De Caluwé et al. | Tamarindus indica L.–A review of traditional uses, phytochemistry and pharmacology | |
KR20090044840A (en) | Natural powdered food using wild flowers and beverage thereof | |
KR101919770B1 (en) | Manufacturing Method of Functional Foods Utilized White Grub | |
KR102107387B1 (en) | Beverage composition for treating hangover comprising black ginseng extact | |
KR101888549B1 (en) | Diet beverage comprising white grup and preparation method thereof | |
KR20200074985A (en) | High quality bamboo powder and its manufacturing method and use | |
KR20160117034A (en) | Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof | |
KR101665584B1 (en) | Composition for eliminating hangover | |
KR101837158B1 (en) | Meat sauce using fermented rice bran products and manufacturing method thereby | |
Adeniyi et al. | Comparative phytochemical and antinutritional constituents of Nigeria sweet and bitter honey varieties | |
KR20220154923A (en) | A process for the preparation of garlic bamboo salt and the garlic bamboo salt prepared therefrom | |
Gandji et al. | Nutritional and functional properties of four traditional mucilaginous vegetables used by rural populations in Benin republic | |
KR101023450B1 (en) | Manufacturing method of kimchi | |
KR100337472B1 (en) | Health food beverage composition containing prickly pear extract | |
KR101201987B1 (en) | Method of manufacturing functional sea tangle for boiled rice with sea tangle | |
KR102020931B1 (en) | Method for producing functional healthful soup containing edible insect | |
KR100584782B1 (en) | Method for preparing composite flavoring materials of garlic bamboo salt or garlic salt | |
KR102414793B1 (en) | A process for the preparation of an onion juice comprising pine needle extracts and the onion juice comprising pine needle extracts prepared therefrom | |
KR100739236B1 (en) | Dried croaker soaked with leaves of the bamboo and preparation method thereof | |
KR102347579B1 (en) | Salt coated with onion, garlic peel and coffee meal extracts and the process for the preparation thereof | |
KR101773251B1 (en) | The manufacturing method of making healthcare compositions comprising fermented Cudrania tricuspidata extracts and herbal medicines Abalone extracts | |
KR102538184B1 (en) | A process for the preparation of pumpkin tea and the pumpkin tea prepared therefrom | |
KR102352258B1 (en) | An anchovy coated with herbal extracts and the process for the preparation thereof | |
CN109362924B (en) | Quercus liaotungensis leaf health tea and preparation method thereof | |
JP2724524B2 (en) | Constipation improvement / treatment agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |